IP Library › Assignment 013692/0021
Patent Assignment
Reel/Frame 013692/0021

Assignment of Assignor's Interest

Recorded: 2003-01-23 Pages: 4
Assignors
CHAPLIN, DAVID J.
Executed: 2002-12-10
PREZIOSO, JOSEPH ANTHONY
Executed: 2002-12-10
EDVARDSEN, KLAUS
Executed: 2002-12-15
Assignee
OXIGENE, INC.
321 ARSENAL STREET, WATERTOWN, MASSACHUSETTS, 02472
Covered Property (1)
Functionalized Stilbene Derivatives as Improved Vascular Targeting Agents
Patent: 6,919,324 →
Application: 10/281,528 →
Publication: US 2003/0149003
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 11, 2004
From: GARNER, CHARLES M., III; KANE, ROBERT R.; PINNEY, KEVIN G.
To: BAYLOR UNIVERSITY
Reel/Frame 015314/0848 →
Change of Assignee Address Mar 10, 2008
From: OXIGENE, INC.
To: OXIGENE, INC.
Reel/Frame 020617/0673 →
Corrective Assignment to Correct the Execution Date for Klaus Edvardsen Previously Recorded at Reel: 013692 Frame: 0021. Assignor(S) Hereby Confirms the Assignment . Jun 29, 2016
From: CHAPLIN, DAVID J.; PREZIOSO, JOSEPH ANTHONY; EDVARDSEN, KLAUS
To: OXIGENE, INC.
Reel/Frame 039207/0404 →
Change of Name Jul 26, 2016
From: OXIGENE, INC.
To: MATEON THERAPEUTICS, INC.
Reel/Frame 039264/0377 →